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Figure 1. Effects of growth and proliferation.
(A) Cell-size homeostasis is dependent upon a balance between growth and proliferation.
(B) A decrease in growth or an increase in proliferation results in a reduction of cell size.
(C) In contrast, an increase in growth or a decrease in proliferation produces large cells.
(D,E) In normal untreated liver, hepatocytes are quiescent — i.e., they do not grow or divide.
(D) Following a partial hepatectomy, hepatocytes are stimulated to grow and divide in a bal-
anced manner, so cell size remains unchanged. (E) However, when proliferation is blocked
(e.g. in cells lacking Cdk1), organ regeneration after a partial hepatectomy occurs predomi-
nately by cell growth and results in severe hypertrophy.Jill Wright and Brandt L. Schneider*
‘‘Being so many different sizes in a day
is very confusing,’’ says Alice to the
caterpillar, as told by Lewis Carroll in
Alice in Wonderland. In her simple
declaration, Alice eloquently
summarizes one of the most
fundamental dilemmas in biology. Size
matters. Yet, no one size fits all.
Remarkably, while organisms display a
nearly incomprehensible range of
sizes — e.g. the giant Sequoia is nearly
100 billion times larger than the
smallest bacterium— cells from similar
lineages are strikingly homogeneous in
size [1]. As such, organism size is
largely dictated by cell number rather
than cell size. Humans are larger than
mice because we have approximately
3,000 timesmore cells [2]. Nonetheless,
the size of individual cells is often very
mutable. A human oocyte can grow to
nearly ten times the size of the average
cell. How can cell size be both constant
and variant? Therein lies the rub.
Genetic studies in yeast suggest that
the coordination of cell growth with
proliferation is essential for cell-size
homeostasis [3,4]. However, despite
decades of work, the molecular
mechanisms that couple growth to cell
division remain poorly understood.
A number of recent studies have led to
the suggestion that a coordinated
interplay between cell size and gene
expression may be intimately involved
in cell size homeostasis [5–9]. Now,
elegant results from a new study
recently published in Current Biology
by Miettinen et al. [10] enter the fray.
Using genomic and metabolomic
approaches, the authors have
uncovered the somewhat surprising
observation that reduced
mitochondrial gene expression
and decreased lipid synthesis may
actually increase cell growth.
The specific molecular mechanisms
whereby cell-size homeostasis is
maintained have eluded scientists
for more than 50 years. On the surface,
the solution would appear to be
conceptually simple. Balancing cell
growth with division rates is sufficient
for establishing cell size homeostasis
(Figure 1A). However, even minutechanges will rapidly disrupt the
balance. Decreasing growth rate
without a compensatory reduction in
proliferation rates will decrease cell
size (Figure 1B). The converse is also
true: increasing growth rate in lieu of
increased cell division rates will
produce large cells (Figure 1C).
Therefore, cells must have a meansfor balancing growth with division.
The yeast paradigm proposes that
cell-cycle progression is blocked until
cells attain a minimum size [11]. In this
manner, proliferation is coupled to cell
size. While genetic studies have
identified a number of highly conserved
genes that are integrally involved in
linking cell size to proliferative
capacity, a number of questions still
remain [12,13]. How does a cell know
how big it is? How does a cell know
how big it should be? How does growth
to a specific cell size trigger cell-cycle
progression?
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Figure 2. Cell size inversely correlates with
lipid levels.
Reduction of mitochondrial metabolism and
lipid synthesis (shown by the red triangle)
results in increased cell-cycle time (i.e. de-
creased proliferation rates) and increased
relative cell growth, producing abnormally
large cells.
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approach to address these questions.
The liver is a remarkably regenerative
organ. Removal of nearly
three-quarters of a mouse liver — i.e.
partial hepatectomy — induces the
remaining hepatocytes to grow and
proliferate to replace the lost tissue
(Figure 1D). Under these conditions,
cell-size homeostasis is maintained.
Miettinen et al. [10] ablated expression
of cyclin-dependent kinase 1 (Cdk1)
specifically in adult mouse liver
hepatocytes; since Cdk1 is essential
for cell-cycle progression, hepatocytes
lacking Cdk1 are unable to proliferate.
Nonetheless, these authors found that
blocking proliferation had little impact
on cell growth: the end result was that
excessive growth (hypertrophy)
produced abnormally large cells that
fully regenerated the liver (Figure 1E).
After utilizing this approach to
disconnect cell size from proliferative
capacity, the authors subsequently
used RNA sequencing to examine how
cell size differentially affects gene
expression. Very few studies have
examined the relationship between cell
size and gene expression in metazoans
[10,14]. As expected, larger cells
upregulated structural genes involved
in cell growth, but unpredictably, many
genes involved in mitochondrial
function were significantly repressed in
these cells [10]. This was particularly
surprising, given that previous studies
have indicated that the loss of
mitochondrial genes is closely
associated with decreased rather than
increased cell size [12,13]. Importantly,control experiments confirmed that the
repression of mitochondrial genes was
a size-dependent effect. In addition,
complementary experiments
performed in Drosophila Kc167 cells
substantiated the observation that
cellular hypertrophy represses
mitochondrial gene expression [10].
The authors backed up this
impressive array of gene expression
data with a systematic metabolomics
approach. Repression of mitochondrial
gene expression suggested that
mitochondrial structure or function
might be impacted. Interestingly,
larger cells displayed no obvious
mitochondrial defects or decrease
in ATP production [10]. In contrast,
metabolic data indicated that
increased cell size concomitantly
upregulated glycolysis. However,
what sets this new work apart is the
examination of the impact of
pharmacological mitochondrial
inhibitors on the size and proliferative
capacity of cells.
By using a panel of small-molecule
inhibitors that target mitochondria
and/or repress metabolic pathways
involved in glycolysis and the pentose
phosphate pathway, Miettinen et al.
[10] progress from descriptive
observations to a mechanistic
approach. Strikingly, the authors found
that inhibiting mitochondrial function
(e.g., the use of minocycline or
thiostrepton to inhibit mitochondrial
translation, Mdivi-1 to inhibit
mitochondrial fission, or the
uncoupling agents FCCP and CCCP)
increased cell size and decreased
proliferative capacity. Additional
studies revealed that cultured cells that
lacked mitochondrial DNA were also
larger than normal. However, inhibitors
that blocked mitochondrial pathways
involved in oxidative phosphorylation
did not result in cell-size increases [10].
Therefore, the authors investigated
whether additional functions linked
mitochondrial metabolism to cell-size
control.
Another key mitochondrial function
is the production of acetyl-coenzyme
A, a precursor for lipid biosynthesis.
Metabolomics indicated that key
mitochondrial transporters (e.g., the
citrate transporter SLC25A1 and the
pyruvate transporter BRP44) were
repressed in large cells. In addition,
depletion of SLC25A1 and its
transcriptional activator PGC-1a
recapitulated the size results [10].
However, providing these cells with acocktail of commercially produced
lipids rescued the size defect.
Moreover, the addition of lipids also
promoted proliferation and reduced
size in untreated cells [10], in line with
other studies that have demonstrated a
lipid-synthesis requirement for
cell-cycle progression [15]. Additional
investigations by Miettinen et al. [10]
revealed that several key transcription
factors involved in lipid biosynthesis
were downregulated in large cells.
Furthermore, pharmacological
inhibition of lipid biosynthesis
increased cell size and decreased
proliferation rates. The take-home
message is that mitochondrial function
and lipid biosynthesis are integrally
involved in balancing cell growth with
proliferation, leading to the proposal of
an intriguing model (Figure 2). In this
hypothetical feedback inhibition
model, excess lipids repress fatty acid
biosynthesis, which results in reduced
mitochondrial function, decreased
proliferative potential, and increased
cell size. Implicit in this model is the
possibility that cells use the build-up
of unused lipids to sense cell size.
However, one problem with such a
model is that it is difficult to determine
whether lipid levels are modulating cell
size or vice versa.
The very interesting yet unexpected
observations made by Miettinen et al.
[10] provide new fodder for further
studies to address a number of
intriguing questions. First, yeast
studies suggest that a decrease in
mitochondrial function reduces rather
than increases cell size [12,13]: how
can this difference be explained?
Second, it is widely believed that a
decline in transport efficiency and
diffusion-limited processes result in
energy deprivation, which in turn limits
cell size [1]. There is no evidence from
these studies that the recovering
hepatocytes are bioenergetically
challenged. Therefore, it appears that
physics of cell growth may directly
impact gene expression and metabolic
regulation. However, these effects are
remarkably complex and may involve
the molecular sensing of specific lipid
species. What molecules are involved,
and would they stimulate proliferation
in physiologically quiescent cells?
Finally, there is growing evidence that
hypertrophy can limit the lifespan of
cells [16–19]. Thus, when organ
recovery is dominated by increases in
cell size rather than cell number is there
a detrimental trade-off? The hypothesis
Dispatch
R285that the availability of lipids may
regulate proliferative potential is also
entering the clinical arena where
ongoing studies are evaluating the
efficacy of lipid-lowering statins as
anti-cancer drugs [14,20]. These
intriguing new observations by
Miettinen et al. [10] reveal that the
molecular and genetic pathways that
balance cell growth with proliferation
are perhaps even more complicated
than previously suspected.References
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in the Fish BrainIn zebrafish, the dorsal habenula shows conspicuous left-right differences.
New research shows that the left and right habenula differentially process
visual and olfactory information. Spontaneous activity in habenular circuits
may lead to activation of distinct neuronal targets and behavioral programs.Hitoshi Okamoto
The majority of the human population
can control the right hand more
skillfully than the left hand. Likewise,
the left half of the human face is in most
cases better at expressing a smile
than the right half [1]. From such
observations, it has been inferred that
the left and right hemispheres of the
human brain show functional
differences. In the 19th century, Dax
and Broca discovered a lesion in the
left hemisphere of post-mortem brains
in patients with severe impairment in
speech ability [2,3], and subsequently,
Wernicke found that a damage to
another region of the left hemisphere
was associated with an impairment of
language comprehension [4]. These
discoveries for the first time provided
the evidence that human language
ability is controlled by the twodistinct areas of the left cortex. In the
20th century, by careful observation
of the patients with a split brain in
which the corpus callosum, the nerve
fiber bundles connecting the left
and right hemispheres reciprocally,
was surgically severed, Sperry
demonstrated that — by and
large — the left hemisphere is
specialized for logical thinking and
language processing, while the right
hemisphere is more adapted for shape
recognition, or emotional and artistic
functions [5]. It certainly might be a
more efficient and universal strategy
for expanding the capacity of the brain
to have two hemispheres of the brain
engaged in information processing
of different categories rather than
having them dedicated to redundantly
same subjects. Indeed, functional
asymmetry of the brain has been found
in other animals, too. For example,the two hemispheres of birds display
a complementary pattern of visual
analysis. The left hemisphere is
specialized for detailed object analysis,
attends to local features and excels
in the categorization of visual stimuli.
In contrast, the right hemisphere
extracts relational configurations of
visual stimuli that can be relevant
during spatial orientation [6]. Now, two
reports by Dreosti et al. [7] and Jetti
et al. [8] in this issue of Current Biology
demonstrate that the left and right
habenula in zebrafish have a distinct
difference in the modality of sensory
information which they process, i.e. the
left and right dHb differentially process
visual and olfactory information,
respectively.
Although some areas of the human
brain, such as the planum temporale
[9], show anatomical asymmetry and
several molecules such as LMO4 have
been identified to be expressed
asymmetrically in both hemispheres
[10], it has been difficult to decisively
attribute genes to the establishment
of brain asymmetry only by studying
humans. It is evident that genetically
tractable model animals are required to
understand the functional, anatomical
and genetic basis of brain laterality.
However, this has been difficult in mice,
